Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Tetanus × CNS × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1 Classical hematology 1 CNS 1

Conditions

Brain Neoplasms 1971 Glioblastoma 1699 Glioma 1193 Central Nervous System Neoplasms 592 Astrocytoma 567 Neuroblastoma 550 Gliosarcoma 420 Oligodendroglioma 350 Neoplasms 344 Breast Neoplasms 281 Medulloblastoma 254 Carcinoma, Non-Small-Cell Lung 211 Meningioma 200 Recurrence 189 Sarcoma 185 Melanoma 177 Ependymoma 177 Neoplasm Metastasis 170 Lung Neoplasms 160 Neurofibromatosis 1 148 Lymphoma 134 Osteosarcoma 116 Meningeal Carcinomatosis 112 Wilms Tumor 109 Ovarian Neoplasms 109 Precursor Cell Lymphoblastic Leukemia-Lymphoma 102 Lymphoma, Non-Hodgkin 102 Diffuse Intrinsic Pontine Glioma 99 Rhabdomyosarcoma 95 Head and Neck Neoplasms 92

Interventions

sargramostim 1 Temozolomide 1 Granulocyte-Macrophage Colony-Stimulating Factor 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03927222 2024-04-08

I-ATTAC

Duke University

Phase 2 Terminated

6 enrolled 7 charts

Glioblastoma, Tetanus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡